• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $BFRG

    Bullfrog AI Holdings Inc.

    Subscribe to $BFRG
    $BFRG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2023

    Exchange: NASDAQ

    Recent Analyst Ratings for Bullfrog AI Holdings Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Bullfrog AI Holdings Inc. SEC Filings

    See more
    • SEC Form 10-Q filed by Bullfrog AI Holdings Inc.

      10-Q - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      5/13/25 4:10:43 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Bullfrog AI Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      4/28/25 9:00:30 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B5 filed by Bullfrog AI Holdings Inc.

      424B5 - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      4/25/25 5:29:26 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Bullfrog AI Holdings Inc.

      SCHEDULE 13G/A - BullFrog AI Holdings, Inc. (0001829247) (Subject)

      4/24/25 11:02:13 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-K filed by Bullfrog AI Holdings Inc.

      10-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      3/14/25 4:10:46 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Bullfrog AI Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      2/27/25 4:15:33 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SCHEDULE 13G filed by Bullfrog AI Holdings Inc.

      SCHEDULE 13G - BullFrog AI Holdings, Inc. (0001829247) (Subject)

      1/14/25 9:30:13 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Bullfrog AI Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      12/27/24 4:05:20 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Bullfrog AI Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

      8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      12/17/24 5:23:00 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Bullfrog AI Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer)

      12/12/24 4:15:33 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Bullfrog AI Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Join Bullfrog AI's Exclusive Live Investor Webinar and Q&A Session on April 23

      GAITHERSBURG, Md., April 17, 2025 (GLOBE NEWSWIRE) -- Bullfrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on April 23, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Vin Singh, CEO of Bullfrog AI. Attendees will gain insight into Bullfrog AI's innovative use of artificial intelligence and machine learning to revolutionize drug development. The Company's proprietary bfLEAP™ platform, developed at Johns Hopk

      4/17/25 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial

      GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its entry into a collaboration agreement with Eleison Pharmaceuticals Inc. ("Eleison"), a Phase 3 oncology company focused on novel chemotherapeutic treatments for rare cancers. Under the terms of the agreement, BullFrog AI will provide access to its BullFrog Data Networks™ AI solution to enhance clinical trial efficiency and patient insights. Financial terms of the coll

      2/27/25 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week

      GAITHERSBURG, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its participation in the TechBio track at Biotech Showcase and RESI JPM, both taking place during the annual JP Morgan Healthcare Conference in San Francisco, January 13–16, 2025. At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks®, a data insights tool powered by the bfLEAP™ platform. BullFrog Data Networks® eva

      1/10/25 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Issues Letter to Stockholders

      GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, issued a letter to stockholders from its CEO Vin Singh. Dear Fellow Stockholders, As the year comes to a close, I want to extend my deepest gratitude for your unwavering support and belief in our mission to revolutionize drug development. Your commitment fuels our drive to innovate and achieve transformational milestones. In thinking back on this past year, it is evident that 2024 wa

      12/27/24 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Announces Appointment of Chief Financial Officer

      GAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of Josh Blacher as its Chief Financial Officer (CFO), effective immediately. This appointment comes in the wake of the untimely passing of Dane Saglio, BullFrog AI's former CFO, who recently lost his battle with cancer. "Dane's contributions to BullFrog AI were immeasurable. Beyond his exceptional expertise and dedication, Dane was a trusted advisor and

      12/17/24 4:30:00 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI's VP Artificial Intelligence to Present at Google's Cancer AI Symposium

      GAITHERSBURG, Md., Oct. 22, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its VP Artificial Intelligence, Enrique García-Rivera, Ph.D., will present at Google's inaugural Cancer AI Symposium on October 30, 2024, at the Boston Center for the Arts. Dr. García-Rivera's presentation will showcase BullFrog AI's groundbreaking use of artificial intelligence in drug discovery and development. Highlighting the Company's proprietary bfLEAP™ platform, the pres

      10/22/24 7:30:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

      JERSEY CITY, N.J., Oct. 21, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today it has closed its previously announced definitive agreement for the purchase and sale of an aggregate of 1,565,000 shares of common stock (or common stock equivalents in lieu thereof) in a registered direct offering and, in a concurrent private placement, com

      10/21/24 1:00:00 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

      GAITHERSBURG, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today it has closed its previously announced definitive agreement for the purchase and sale of an aggregate of 1,565,000 shares of common stock (or common stock equivalents in lieu thereof) in a registered direct offering and, in a concurrent private placement, common warrants to purchase up to 1,565,000 shares of common stock (together with the registered direct offering) at

      10/21/24 11:45:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

      JERSEY CITY, N.J., Oct. 18, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, has entered into a definitive agreement for the purchase and sale of an aggregate of 1,565,000 shares of common stock (or common stock equivalents in lieu thereof) in a registered direct offering and, in a concurrent private placement, common warrants to purchase up to 1,565,00

      10/18/24 12:01:00 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

      GAITHERSBURG, Md., Oct. 18, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today it has entered into a definitive agreement for the purchase and sale of an aggregate of 1,565,000 shares of common stock (or common stock equivalents in lieu thereof) in a registered direct offering and, in a concurrent private placement, common warrants to purchase up to 1,565,000 shares of common stock (together with the registered direct offering) at a combined purch

      10/18/24 9:30:54 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Bullfrog AI Holdings Inc. Leadership Updates

    Live Leadership Updates

    See more
    • BullFrog AI Issues Letter to Stockholders

      GAITHERSBURG, Md., Dec. 27, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, issued a letter to stockholders from its CEO Vin Singh. Dear Fellow Stockholders, As the year comes to a close, I want to extend my deepest gratitude for your unwavering support and belief in our mission to revolutionize drug development. Your commitment fuels our drive to innovate and achieve transformational milestones. In thinking back on this past year, it is evident that 2024 wa

      12/27/24 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Announces Appointment of Chief Financial Officer

      GAITHERSBURG, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of Josh Blacher as its Chief Financial Officer (CFO), effective immediately. This appointment comes in the wake of the untimely passing of Dane Saglio, BullFrog AI's former CFO, who recently lost his battle with cancer. "Dane's contributions to BullFrog AI were immeasurable. Beyond his exceptional expertise and dedication, Dane was a trusted advisor and

      12/17/24 4:30:00 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

      GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of John Baldoni, Ph.D., to its Scientific Advisory Board. Dr. Baldoni brings over four decades of experience in the pharmaceutical industry, including leadership roles in scientific research and technology-driven drug discovery. Dr. Baldoni's career includes 29 years in R&D at GSK, where he served as Senior Vice President of Platform and Technology Sciences, lea

      10/15/24 7:30:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

      The study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCCThe findings suggest that targeting β2-spectrin with BF-114 can prevent the progression of liver diseasesNew data builds on earlier studies and further supports BF-114's potential to address major unmet needs in treating obesity-related liver diseasesDr. Lopa Mishra, a globally recognized expert in liver disease, has joined BullFrog AI's Scientific Advisory Board to provide strategic insights for advancing BF-114 GAITHERSBURG, Md., Oct. 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFr

      10/9/24 7:30:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

      GAITHERSBURG, Md., Feb. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of Dr. Thomas W. Chittenden, PhD, DPhil, PStat, as its new Chief Scientific Officer. With a distinguished career at the intersection of artificial intelligence, machine learning, drug discovery, and biostatistics, Dr. Chittenden brings a wealth of experience and a proven track record of leadership in scientific research and development to BullFrog AI. W

      2/26/24 8:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

      GAITHERSBURG, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of two distinguished scientific advisors to its advisory board: Gwenn S. Smith, PhD, and Jeremiah Wala, MD, PhD. "We are thrilled to welcome Dr. Smith and Dr. Wala to our advisory board," said Vin Singh, CEO of BullFrog AI. "Their remarkable achievements and deep knowledge in their respective fields will be invaluable as we continue to push the boundari

      1/26/24 7:30:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Announces Appointment of Enrique García-Rivera as Vice President of Artificial Intelligence

      GAITHERSBURG, Md., July 11, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a precision medicine company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of Enrique García-Rivera, Ph.D., as its new Vice President of Artificial Intelligence. The appointment will further advance BullFrog AI's best-in-class proprietary bfLEAP™ AI platform that is engineered to enable more accurate predictions of patient disease progression and improve the design of clinical trials to speed safe and effective drug development. "We are excite

      7/11/23 7:00:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI Continues to Expand Team with Appointment of New VP of Business Development

      GAITHERSBURG, Md., June 07, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a digital technology company using machine learning to usher in a new era of precision medicine, today announced the appointment of Toby Sayre, MS as VP of Business Development. Sayre brings more than 18 years of experience in life sciences and biotechnology consulting, business development, product development, and client engagement to BullFrog AI. He holds master's degrees in Cell and Molecular Biology and Biochemistry from San Francisco State University (SFSU) and University of California, Los Angeles (UCLA), and has a technical background in bioinfor

      6/7/23 6:30:00 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Bullfrog AI Holdings Inc. Financials

    Live finance-specific insights

    See more
    • BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / April 26, 2024 / RedChip Companies will air interviews with BullFrog AI Holdings, Inc. (NASDAQ:BFRG) and GreenPower Motor Company Inc. (NASDAQ:GP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, April 27, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:BullFrog AI: https://www.redchip.com/assets/access/bfrg_accessGreenPower: https://www.redchip.com/assets/access/gp_accessIn an exclusive interview, Vin Singh, CEO of BullFrog AI, appears on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV to provide a corporate u

      4/26/24 9:00:00 AM ET
      $BFRG
      $GP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Construction/Ag Equipment/Trucks
      Consumer Discretionary
    • ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / October 27, 2023 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG)(NASDAQ:BFRGW) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, October 28, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:ASP Isotopes: https://www.redchip.com/assets/access/aspi_accessBullfrog AI: https://www.redchip.com/assets/access/bfrg_accessPaul Mann, CEO, of ASP Isotopes appears on the RedChip Small Stocks Big Money® Show on Bloomberg TV to provide a corporate update. ASP Isoto

      10/27/23 9:00:00 AM ET
      $ASPI
      $BFRG
      Major Chemicals
      Industrials
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • RedChip Launches 'Small Stocks, Big Money' Podcast

      New podcast series shines a spotlight on undervalued small-cap and microcap stocksORLANDO, FL / ACCESSWIRE / August 2, 2023 / RedChip Companies, a renowned international investor relations firm specializing in microcap and small-cap companies,announce the launch of its much-anticipated podcast series, "Small Stocks, Big Money."Hosted by RedChip CEO Dave Gentry and Associate Director Barrett Boone, the "Small Stocks, Big Money" podcast aims to offer a first-hand look at undiscovered small-cap and microcap stocks before they catch the attention of bigger Wall Street players. The series features in-depth interviews with executives from some of the top names in smaller cap stocks, providing list

      8/2/23 12:45:00 PM ET
      $BFRG
      $LTRN
      $RVPH
      $STSS
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Dental Instruments
      Pharmaceuticals and Biotechnology
    • Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

      ORLANDO, FL / ACCESSWIRE / May 19, 2023 / RedChip Companies will air new interviews with Sharps Technology, Inc. (NASDAQ:STSS, STSSW))) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 20, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Sharps Technology, Inc.: https://www.stssinfo.com/interview_accessBullFrog AI Holdings, Inc.: https://bfrginfo.com/interview_accessAbout The RedChip Money Report®The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' ex

      5/19/23 9:00:00 AM ET
      $BFRG
      $STSS
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Dental Instruments
    • BullFrog AI and Alarum Technologies Ltd. Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)

      ORLANDO, FL / ACCESSWIRE / April 14, 2023 / RedChip Companies will air interviews with BullFrog AI (NASDAQ:BFRG) and Alarum Technologies Ltd. (NASDAQ:ALAR) on The RedChip Money Report® on Bloomberg TV, this Saturday, April 15, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:BullFrog AI (NASDAQ:BFRG): https://bfrginfo.com/interview_accessAlarum Technologies Ltd. (NASDAQ:ALAR): https://alarinfo.com/interview_accessAbout The RedChip Money Report®The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Di

      4/14/23 9:40:00 AM ET
      $ALAR
      $BFRG
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BullFrog AI and Sharps Technology Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)

      ORLANDO, FL / ACCESSWIRE / April 5, 2023 / RedChip Companies will air new interviews with BullFrog AI (NASDAQ:BFRG) and Sharps Technology (NASDAQ:STSS) on The RedChip Money Report® on Bloomberg TV, this Saturday, April 8, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:BullFrog AI (NASDAQ:BFRG): https://bfrginfo.com/interview_accessSharps Technology (NASDAQ:STSS): https://www.stssinfo.com/interview_accessAbout The RedChip Money Report®The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Discoverin

      4/5/23 7:05:00 AM ET
      $BFRG
      $STSS
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Dental Instruments

    Bullfrog AI Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Singh Vininder sold $7,686 worth of shares (5,895 units at $1.30), decreasing direct ownership by 0.25% to 2,342,446 units (SEC Form 4)

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      4/4/25 4:18:50 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Singh Vininder sold $66,408 worth of shares (44,105 units at $1.51), decreasing direct ownership by 2% to 2,348,341 units (SEC Form 4)

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      4/3/25 8:44:44 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 5 filed by Elsey R Don

      5 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      2/12/25 9:00:14 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 5 filed by Enright William

      5 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      2/12/25 9:00:13 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 5 filed by Hanson Jason David

      5 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      2/12/25 9:00:14 AM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Chief Executive Officer Singh Vininder

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      1/30/25 4:05:24 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Singh Vininder sold $107,458 worth of shares (50,000 units at $2.15), decreasing direct ownership by 2% to 2,392,446 units (SEC Form 4)

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      1/6/25 5:07:31 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 3 filed by new insider Blacher Joshua

      3 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      12/17/24 5:25:34 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Singh Vininder sold $14,727 worth of shares (5,695 units at $2.59), decreasing direct ownership by 0.23% to 2,442,446 units (SEC Form 4)

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      10/11/24 4:41:29 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Executive Officer Singh Vininder sold $49,755 worth of shares (18,872 units at $2.64), decreasing direct ownership by 0.76% to 2,448,141 units (SEC Form 4)

      4 - BullFrog AI Holdings, Inc. (0001829247) (Issuer)

      10/8/24 8:51:50 PM ET
      $BFRG
      Biotechnology: Pharmaceutical Preparations
      Health Care